Publications (210) SILVIA MARÍA SÁNCHEZ RAMÓN publications

filter_list

2025

  1. Anti-PL-7/PL-12 antisynthetase syndrome associated with interstitial lung disease following SARS-COV-2 infection and vaccination: A case study review

    Heliyon, Vol. 11, Núm. 2

  2. Análisis descriptivo de alteraciones inmunológicas en el fallo reproductivo recurrente y resultados terapéuticos

    Medwave, Vol. 25, Núm. 5, pp. e3037

  3. Association between human leukocyte antigen E expression and outcomes in solid tumors: a systematic review and meta-analysis

    Frontiers in Oncology, Vol. 15

  4. Choroid plexus volume is enlarged in long COVID and associated with cognitive and brain changes

    Molecular Psychiatry, Vol. 30, Núm. 7, pp. 2821-2830

  5. Correction: Recurrent reproductive failure and celiac genetic susceptibility, a leading role of gluten (Frontiers in Immunology, (2024), 15, (1451552), 10.3389/fimmu.2024.1451552)

    Frontiers in Immunology

  6. Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders

    Journal of Clinical Immunology, Vol. 45, Núm. 1

  7. Erratum: Correction to: Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders (Journal of clinical immunology (2024) 45 1 DOI: 10.1007/s10875-024-01818-2.)

    Journal of clinical immunology

  8. IEIVariantFilter: a bioinformatics tool to speed up genetic diagnosis of inborn errors of immunity patients

    NAR GENOMICS AND BIOINFORMATICS, Vol. 7, Núm. 2

  9. Long-term effects of COVID-19 in patients with primary immunodeficiency: An IPOPI worldwide survey

    Journal of Allergy and Clinical Immunology, Vol. 156, Núm. 2, pp. 449-462

  10. Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years

    Frontiers in Immunology, Vol. 16

  11. Optimizing diagnostic and management pathways for patients with eosinophilia of unknown origin: a multidisciplinary protocol for urgent and non-urgent evaluation

    Frontiers in Medicine, Vol. 12

  12. Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects

    Expert Review of Clinical Immunology, Vol. 21, Núm. 7, pp. 943-960

  13. Real-World Effectiveness, Safety, and Tolerability of Facilitated Subcutaneous Immunoglobulin 10% in Secondary Immunodeficiency Disease: A Systematic Literature Review

    Journal of Clinical Medicine, Vol. 14, Núm. 4

  14. Spanish Consensus on the Diagnosis and Management of Patients With Activated PI3K Delta Syndrome (APDS)

    Journal of investigational allergology & clinical immunology, Vol. 35, Núm. 2, pp. 87-102

  15. γδ T Cells: Game Changers in Immune Cell Therapy for Cancer

    Cancers, Vol. 17, Núm. 7

2024

  1. An Exploratory Approach of Clinically Useful Biomarkers of Cvid by Logistic Regression

    Journal of Clinical Immunology, Vol. 44, Núm. 6

  2. Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure

    Scientific Reports, Vol. 14, Núm. 1

  3. Charting a course for global progress in PIDs by 2030 — proceedings from the IPOPI global multi-stakeholders’ summit (September 2023)

    Frontiers in Immunology, Vol. 15

  4. Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

    Journal of Medical Virology, Vol. 96, Núm. 6

  5. Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study

    Frontiers in Immunology, Vol. 15